Peripheral Arterial Disease Trial, Recruiting NCT07130526 Sponsor: University Hospital, Essen Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT07130526
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with peripheral artery disease (reduced blood flow in the arteries of the legs)
  • You have significant calcium buildup in your arteries (rated as severe, based on a specific medical scoring system)
  • The blocked or narrowed area being treated is located in specific blood vessels in your hip, groin, or upper leg area (confirm with trial site)
  • You have long-term leg pain, cramping, or wounds caused by poor blood flow, classified at a certain level of severity (confirm with trial site)
  • You are already scheduled to have a procedure to treat a blocked artery in your leg
  • You are between 18 and 85 years old
  • You are willing to attend all required follow-up appointments
  • You are willing to sign a consent form before any study procedures take place

Who may not be able to join:

  • The area being treated cannot be clearly seen on an ultrasound scan
  • The blockage is inside a previously placed stent
  • You have received clot-dissolving treatment within the 3 days before the procedure
  • You have an aneurysm (abnormal bulge) in the femoral or popliteal artery in your leg
  • You have liver problems, a blood clot in a deep vein, a blood clotting disorder, or you take medication that suppresses your immune system
  • You have unstable chest pain (angina) at the time of joining the trial
  • You have had a heart attack or stroke within the last 30 days
  • Your life expectancy is less than 12 months
  • You have a serious blood infection (sepsis) at the time of joining the trial
  • You have a known or suspected active infection anywhere in your body (except a wound on the leg being treated)
  • You are allergic to or cannot take aspirin, clopidogrel, or heparin (common blood-thinning medications)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0201-723-4801

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Essen
Registry
ClinicalTrials.gov
Start date
1 July 2025
Est. completion
20 April 2026

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

FDC

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov